Tag: nasdaq:cprx

June 12, 2019

Catalyst Pharmaceuticals Files Lawsuit Against FDA Over Rival Drug

The company is suing the regulatory agency over the approval of Jacobus Pharmaceutical's rival drug Ruzurgi.
May 19, 2019

5 Top Weekly NASDAQ Biotech and Pharma Stocks: Index in Green

Last week's top NASDAQ biotech and pharma stocks were Harrow Health, Sesen Bio, Zynerba Pharmaceuticals, Athersys and Catalyst Pharmaceuticals.
March 31, 2019

5 Top Weekly NASDAQ Biotech Stocks: Index Rebounds

Aveo Pharmaceuticals, Curis, Phasebio Pharmaceuticals, Arcturus Therapeutics and Krystal Biotech were last week's top gainers.
December 18, 2018

Catalyst Pharmaceuticals Announces Definitive Agreement with Endo for Vigabatrin Tablets

Catalyst Pharmaceuticals (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular...